- 全部
- 热门
- 最新评论
- 最新发帖
- 全部
- 个人号
- 机构号
-
公告 Orchard Therapeutics plc ADR|Contract Adjustment
发表于 2024-01-26 00:00 107次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 08:31 146次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 08:09 142次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 08:02 145次浏览
评论赞 -
公告 Orchard Therapeutics plc ADR|4:持股变动声明
发表于 2024-01-25 08:00 138次浏览
评论赞 -
公告 Orchard Therapeutics plc ADR|4:持股变动声明
发表于 2024-01-25 07:41 146次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 07:40 177次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 07:39 141次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 07:17 148次浏览
评论赞 -
公告 Statement of changes in beneficial ownership of securities
发表于 2024-01-25 07:17 142次浏览
评论赞 -
公告 Securities to be offered to employees in employee benefit plans, post-effective
发表于 2024-01-25 06:11 149次浏览
评论赞 -
公告 Securities to be offered to employees in employee benefit plans, post-effective
发表于 2024-01-25 06:07 141次浏览
评论赞 -
公告 Post-Effective amendments for registration statement
发表于 2024-01-25 05:58 143次浏览
评论赞 -
公告 Securities to be offered to employees in employee benefit plans, post-effective
发表于 2024-01-25 05:55 137次浏览
评论赞 -
公告 Securities to be offered to employees in employee benefit plans, post-effective
发表于 2024-01-25 05:51 155次浏览
评论赞 -
公告 Securities to be offered to employees in employee benefit plans, post-effective
发表于 2024-01-25 05:50 149次浏览
评论赞 -
公告 Securities to be offered to employees in employee benefit plans, post-effective
发表于 2024-01-25 05:50 148次浏览
评论赞 -
公告 Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, and 9.01
发表于 2024-01-25 05:38 159次浏览
评论赞 -
公告 Post-Effective amendments for registration statement
发表于 2024-01-25 05:34 142次浏览
评论赞 -
公告 Notification filed by national security exchange to report the removal from lis
发表于 2024-01-24 21:50 146次浏览
评论赞